Back to search

Article

The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depressive Disorder and/or Generalized Anxiety Disorder: A Phase 1, Open-Label Study

2021-04-08

Abstract excerpt

<h4>Background: </h4> Recent studies have investigated the potential of treatments that modify the gut microbiome, such as fecal microbiota transplantation (FMT) and probiotics, in individuals with psychiatric illnesses. The aim of this study was to investigate the safety, tolerability, and efficacy of a novel gut microbiome therapeutic, Microbial Ecosystem Therapuetic-2 (MET-2), in people with depression and anxi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
1659d994-be43-5da5-a6f8-0aae624ac2a3
DOI
10.21203/rs.3.rs-374466/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
The Safety, Efficacy, and Tolerability of Microbial Ecosystem Therapeutic-2 in People With Major Depressive Disorder and/or Generalized Anxiety Disorder: A Phase 1, Open-Label StudyDOI 10.21203/rs.3.rs-374466/v1
Select a neighboring publication to make it the new centre.